BEUDAMED
    FDA Adverse Event Injury Summary report: N

    UNKNOWN SUSPENSORY FIXATION DEV

    MDR report key: 17322160 · Received July 13, 2023

    Report

    Report Number
    1219602-2023-01201
    Event Type
    Injury
    Date Received
    July 13, 2023
    Date of Event
    December 1, 2022
    Report Date
    September 6, 2023
    Manufacturer
    SMITH & NEPHEW, INC.
    Product Code
    MBI
    PMA / PMN Number
    K980155
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    HK
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    H11: H2: CORRECTION ON B5 AND G2.

    Additional Manufacturer Narrative · 0

    H10: INTERNAL COMPLAINT REFERENCE: (B)(4). THIS COMPLAINT WAS OPENED BY SMITH+NEPHEW TO DOCUMENT A PATIENT COMPLICATION IDENTIFIED THROUGH A REVIEW OF CLINICAL EVIDENCE FROM LITERATURE SOURCES THAT INCLUDES REFERENCE TO THE USE OF A SMITH+NEPHEW PRODUCT. THE REPORTED ISSUE(S) RELATE TO KNOWN INHERENT PROCEDURAL RISKS THAT ARE APPROPRIATELY DOCUMENTED IN OUR RISK FILES. SMITH+NEPHEW WILL CONTINUE TO MONITOR TRENDS IN ACCORDANCE WITH OUR POST-MARKET SURVEILLANCE PROCESS AND TAKE NECESSARY ACTION AS REQUIRED IF ANTICIPATED SEVERITY AND/OR OCCURRENCE RATES ARE EXCEEDED. SMITH+NEPHEW HAS NO REASON TO SUSPECT THAT THE PRODUCT FAILED TO MEET ANY SPECIFICATIONS AT THE TIME OF MANUFACTURE. BASED ON OUR REVIEW OF ALL CURRENTLY AVAILABLE INFORMATION, WE ARE UNABLE TO CONFIRM A RELATIONSHIP BETWEEN THE REPORTED EVENT AND THE DEVICE OR IDENTIFY A DEFINITIVE ROOT CAUSE. HOWEVER, AS THE USE OF OUR PRODUCT CANNOT BE EXCLUDED AS A POTENTIAL CAUSE OR CONTRIBUTORY FACTOR TO THE REPORTED ISSUE, WE ARE CONSERVATIVELY SUBMITTING THIS REPORT IN ACCORDANCE WITH APPLICABLE REGULATIONS. IF ADDITIONAL INFORMATION BECOMES AVAILABLE THAT ALTERS THE CONCLUSIONS OF THIS REPORT, A FOLLOW-UP REPORT WILL BE SUBMITTED AS REQUIRED. ARTICLE: WAN, K. H. M., LAI, C. Y. S., TANG, S. P. K., NG, E. P. L., MOY, R. L. T., CHAN, W. L., & WONG, K. K. H. (2022). THE USE OF FIVE-STRAND HAMSTRING AUTOGRAFT TO INCREASE THE GRAFT SIZE IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION¿A PROSPECTIVE COHORT STUDY WITH SATISFACTORY EARLY CLINICAL RESULTS. ARTHROSCOPY, SPORTS MEDICINE, AND REHABILITATION, 4(6), E1923-E1931.

    Description of Event or Problem · 0

    IT WAS REPORTED THAT ON LITERATURE REVIEW "THE USE OF FIVE-STRAND HAMSTRING AUTOGRAFT TO INCREASE THE GRAFT SIZE IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION - A PROSPECTIVE COHORT STUDY WITH SATISFACTORY EARLY CLINICAL RESULTS", 1 PATIENT HAD A GRAFT RUPTURE AFTER AN ACL RECONSTRUCTION PROCEDURE USING AN ENDOBUTTON DEVICE. THE EVENT WAS RESOLVED WITH A REVISION SURGERY. PATIENT'S OUTCOME IS UNKNOWN. NO FURTHER INFORMATION IS AVAILABLE.

    Description of Event or Problem · 0

    IT WAS REPORTED THAT ON LITERATURE REVIEW "THE USE OF FIVE-STRAND HAMSTRING AUTOGRAFT TO INCREASE THE GRAFT SIZE IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION - A PROSPECTIVE COHORT STUDY WITH SATISFACTORY EARLY CLINICAL RESULTS", 1 PATIENT HAD A GRAFT RUPTURE AFTER AN ACL RECONSTRUCTION PROCEDURE USING AN ENDOBUTTON DEVICE AND BIOSURE REGENESORB ANCHOR. THE EVENT WAS RESOLVED WITH A REVISION SURGERY. PATIENT'S OUTCOME IS UNKNOWN. NO FURTHER INFORMATION IS AVAILABLE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    692749 UNKNOWN SUSPENSORY FIXATION DEV FASTENER, FIXATION, NONDEGRADABLE, SOFT TISSUE MBI SMITH & NEPHEW, INC. UNKNOWN

    Patients

    Seq Age Sex Outcome Treatment
    1 Unknown Required Intervention| O